Drug Profile
Cholera vaccine live attenuated - Celldex Therapeutics Inc
Alternative Names: CholeraGarde; Live attenuated oral cholera vaccine - Celldex Therapeutics Inc; Peru-15Latest Information Update: 21 Sep 2017
Price :
$50
*
At a glance
- Originator Celldex Therapeutics Inc
- Developer International Vaccine Institute; Vaccine Technologies
- Class Attenuated vaccines; Cholera vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cholera
Most Recent Events
- 21 Sep 2017 Discontinued - Phase-II for Cholera (In infants, Prevention) in Bangladesh (PO)
- 21 Sep 2017 Discontinued - Phase-II for Cholera (In infants, Prevention) in India (PO)
- 21 Sep 2017 Discontinued - Phase-II for Cholera (Prevention) in Thailand (PO)